SrasV1, PubMed, Corpus, bibRecord, 002026

Inhibition and escape of SARS-CoV treated with antisense morpholino oligomers.

Identifieur interne : 002026 ( PubMed/Corpus ); précédent : 002025; suivant : 002027

Inhibition and escape of SARS-CoV treated with antisense morpholino oligomers.

Auteurs : Benjamin W. Neuman ; David A. Stein ; Andrew D. Kroeker ; Hong M. Moulton ; Richard K. Bestwick ; Patrick L. Iversen ; Michael J. Buchmeier

Source :

Advances in experimental medicine and biology [ 0065-2598 ] ; 2006.

RBID : pubmed:17037599

English descriptors

KwdEn :
- Animals, Antiviral Agents (pharmacology), Binding Sites, Humans, Nucleocapsid Proteins (metabolism), Oligonucleotides, Antisense (chemistry), Oligonucleotides, Antisense (genetics), Protein Binding, SARS Virus (genetics), Severe Acute Respiratory Syndrome (genetics), Severe Acute Respiratory Syndrome (therapy).
MESH :
- chemical , chemistry : Oligonucleotides, Antisense.
- chemical , genetics : Oligonucleotides, Antisense.
- chemical , metabolism : Nucleocapsid Proteins.
- chemical , pharmacology : Antiviral Agents.
- genetics : SARS Virus, Severe Acute Respiratory Syndrome.
- therapy : Severe Acute Respiratory Syndrome.
- Animals, Binding Sites, Humans, Protein Binding.

DOI: 10.1007/978-0-387-33012-9_103
PubMed: 17037599

Links to Exploration step

pubmed:17037599

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Inhibition and escape of SARS-CoV treated with antisense morpholino oligomers.</title>
<author><name sortKey="Neuman, Benjamin W" sort="Neuman, Benjamin W" uniqKey="Neuman B" first="Benjamin W" last="Neuman">Benjamin W. Neuman</name>
<affiliation><nlm:affiliation>The Scripps Research Institute, La Jolla, California, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Stein, David A" sort="Stein, David A" uniqKey="Stein D" first="David A" last="Stein">David A. Stein</name>
</author>
<author><name sortKey="Kroeker, Andrew D" sort="Kroeker, Andrew D" uniqKey="Kroeker A" first="Andrew D" last="Kroeker">Andrew D. Kroeker</name>
</author>
<author><name sortKey="Moulton, Hong M" sort="Moulton, Hong M" uniqKey="Moulton H" first="Hong M" last="Moulton">Hong M. Moulton</name>
</author>
<author><name sortKey="Bestwick, Richard K" sort="Bestwick, Richard K" uniqKey="Bestwick R" first="Richard K" last="Bestwick">Richard K. Bestwick</name>
</author>
<author><name sortKey="Iversen, Patrick L" sort="Iversen, Patrick L" uniqKey="Iversen P" first="Patrick L" last="Iversen">Patrick L. Iversen</name>
</author>
<author><name sortKey="Buchmeier, Michael J" sort="Buchmeier, Michael J" uniqKey="Buchmeier M" first="Michael J" last="Buchmeier">Michael J. Buchmeier</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="RBID">pubmed:17037599</idno>
<idno type="pmid">17037599</idno>
<idno type="doi">10.1007/978-0-387-33012-9_103</idno>
<idno type="wicri:Area/PubMed/Corpus">002026</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002026</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Inhibition and escape of SARS-CoV treated with antisense morpholino oligomers.</title>
<author><name sortKey="Neuman, Benjamin W" sort="Neuman, Benjamin W" uniqKey="Neuman B" first="Benjamin W" last="Neuman">Benjamin W. Neuman</name>
<affiliation><nlm:affiliation>The Scripps Research Institute, La Jolla, California, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Stein, David A" sort="Stein, David A" uniqKey="Stein D" first="David A" last="Stein">David A. Stein</name>
</author>
<author><name sortKey="Kroeker, Andrew D" sort="Kroeker, Andrew D" uniqKey="Kroeker A" first="Andrew D" last="Kroeker">Andrew D. Kroeker</name>
</author>
<author><name sortKey="Moulton, Hong M" sort="Moulton, Hong M" uniqKey="Moulton H" first="Hong M" last="Moulton">Hong M. Moulton</name>
</author>
<author><name sortKey="Bestwick, Richard K" sort="Bestwick, Richard K" uniqKey="Bestwick R" first="Richard K" last="Bestwick">Richard K. Bestwick</name>
</author>
<author><name sortKey="Iversen, Patrick L" sort="Iversen, Patrick L" uniqKey="Iversen P" first="Patrick L" last="Iversen">Patrick L. Iversen</name>
</author>
<author><name sortKey="Buchmeier, Michael J" sort="Buchmeier, Michael J" uniqKey="Buchmeier M" first="Michael J" last="Buchmeier">Michael J. Buchmeier</name>
</author>
</analytic>
<series><title level="j">Advances in experimental medicine and biology</title>
<idno type="ISSN">0065-2598</idno>
<imprint><date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Antiviral Agents (pharmacology)</term>
<term>Binding Sites</term>
<term>Humans</term>
<term>Nucleocapsid Proteins (metabolism)</term>
<term>Oligonucleotides, Antisense (chemistry)</term>
<term>Oligonucleotides, Antisense (genetics)</term>
<term>Protein Binding</term>
<term>SARS Virus (genetics)</term>
<term>Severe Acute Respiratory Syndrome (genetics)</term>
<term>Severe Acute Respiratory Syndrome (therapy)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Oligonucleotides, Antisense</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Oligonucleotides, Antisense</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Nucleocapsid Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>SARS Virus</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Binding Sites</term>
<term>Humans</term>
<term>Protein Binding</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17037599</PMID>
<DateCompleted><Year>2006</Year>
<Month>12</Month>
<Day>11</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0065-2598</ISSN>
<JournalIssue CitedMedium="Print"><Volume>581</Volume>
<PubDate><Year>2006</Year>
</PubDate>
</JournalIssue>
<Title>Advances in experimental medicine and biology</Title>
<ISOAbbreviation>Adv. Exp. Med. Biol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Inhibition and escape of SARS-CoV treated with antisense morpholino oligomers.</ArticleTitle>
<Pagination><MedlinePgn>567-71</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Neuman</LastName>
<ForeName>Benjamin W</ForeName>
<Initials>BW</Initials>
<AffiliationInfo><Affiliation>The Scripps Research Institute, La Jolla, California, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Stein</LastName>
<ForeName>David A</ForeName>
<Initials>DA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kroeker</LastName>
<ForeName>Andrew D</ForeName>
<Initials>AD</Initials>
</Author>
<Author ValidYN="Y"><LastName>Moulton</LastName>
<ForeName>Hong M</ForeName>
<Initials>HM</Initials>
</Author>
<Author ValidYN="Y"><LastName>Bestwick</LastName>
<ForeName>Richard K</ForeName>
<Initials>RK</Initials>
</Author>
<Author ValidYN="Y"><LastName>Iversen</LastName>
<ForeName>Patrick L</ForeName>
<Initials>PL</Initials>
</Author>
<Author ValidYN="Y"><LastName>Buchmeier</LastName>
<ForeName>Michael J</ForeName>
<Initials>MJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>AI025913</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>AI059799</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>HHSN266200400058C</GrantID>
<Acronym>HS</Acronym>
<Agency>AHRQ HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>NS41219</GrantID>
<Acronym>NS</Acronym>
<Agency>NINDS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Adv Exp Med Biol</MedlineTA>
<NlmUniqueID>0121103</NlmUniqueID>
<ISSNLinking>0065-2598</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019590">Nucleocapsid Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016376">Oligonucleotides, Antisense</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019590" MajorTopicYN="N">Nucleocapsid Proteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016376" MajorTopicYN="N">Oligonucleotides, Antisense</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>17</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year>
<Month>10</Month>
<Day>14</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2006</Year>
<Month>12</Month>
<Day>12</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2006</Year>
<Month>10</Month>
<Day>14</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">17037599</ArticleId>
<ArticleId IdType="doi">10.1007/978-0-387-33012-9_103</ArticleId>
<ArticleId IdType="pmc">PMC7123819</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Chem Biol. 2004 Sep;11(9):1293-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15380189</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15150417</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Mol Biol. 2003 Aug 29;331(5):991-1004</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12927536</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8709-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15161975</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antisense Nucleic Acid Drug Dev. 1997 Jun;7(3):151-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9212905</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2004 Jun;78(11):5891-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15140987</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochemistry. 2004 May 4;43(17):4906-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15109248</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochim Biophys Acta. 1999 Dec 10;1489(1):141-58</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10807004</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Antisense Nucleic Acid Drug Dev. 1999 Apr;9(2):213-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10355827</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2004 Jul;78(14):7523-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15220426</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Genet. 2000 Oct;26(2):216-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11017081</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nucleic Acids Res. 2005 Feb 01;33(2):796-804</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15687388</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2004 Jul 2;319(3):746-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15184046</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2004 Oct;78(20):11334-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15452254</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10012-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15226499</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2004 Jun;78(11):5957-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15140993</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2004 Mar 20;363(9413):938-47</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15043961</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002026 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002026 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:17037599
   |texte=   Inhibition and escape of SARS-CoV treated with antisense morpholino oligomers.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:17037599" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS

Inhibition and escape of SARS-CoV treated with antisense morpholino oligomers.

Inhibition and escape of SARS-CoV treated with antisense morpholino oligomers.

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki